Lemonade, Inc. (NYSE:LMND – Get Free Report) insider John Sheldon Peters sold 11,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 13th. The shares were sold at an average price of $52.55, for a total value of $578,050.00. Following the completion of the sale, the insider directly owned 76,942 shares of the company’s stock, valued at $4,043,302.10. This trade represents a 12.51% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
John Sheldon Peters also recently made the following trade(s):
- On Monday, July 6th, John Sheldon Peters sold 3,444 shares of Lemonade stock. The shares were sold at an average price of $79.00, for a total value of $272,076.00.
- On Thursday, June 4th, John Sheldon Peters sold 3,608 shares of Lemonade stock. The stock was sold at an average price of $52.94, for a total value of $191,007.52.
- On Wednesday, June 3rd, John Sheldon Peters sold 1,735 shares of Lemonade stock. The stock was sold at an average price of $53.17, for a total value of $92,249.95.
Lemonade Stock Down 5.2%
LMND stock traded down $2.76 during midday trading on Monday, reaching $49.88. 1,222,511 shares of the company’s stock traded hands, compared to its average volume of 1,976,913. The company has a market cap of $3.86 billion, a price-to-earnings ratio of -27.26 and a beta of 1.84. The firm’s fifty day moving average price is $60.43 and its 200-day moving average price is $61.14. Lemonade, Inc. has a 52 week low of $46.16 and a 52 week high of $99.90.
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on LMND shares. Keefe, Bruyette & Woods upgraded Lemonade from an “underperform” rating to a “market perform” rating and set a $48.00 target price on the stock in a report on Thursday, July 30th. UBS Group set a $75.00 price target on shares of Lemonade in a report on Thursday, May 21st. Morgan Stanley reaffirmed an “equal weight” rating and issued a $75.00 price objective on shares of Lemonade in a research report on Wednesday, July 8th. TD Cowen reiterated a “hold” rating on shares of Lemonade in a research note on Monday, June 8th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of Lemonade in a research report on Tuesday, May 26th. Four equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $64.11.
View Our Latest Analysis on LMND
Institutional Investors Weigh In On Lemonade
A number of hedge funds have recently made changes to their positions in the business. Ma Investment Partnership LP purchased a new position in shares of Lemonade in the 2nd quarter worth about $6,505,000. Corient Private Wealth LP purchased a new stake in Lemonade during the second quarter worth about $1,119,000. Parallax Volatility Advisers L.P. purchased a new stake in Lemonade during the second quarter worth about $1,637,000. Bank of America Corp DE bought a new stake in Lemonade in the second quarter worth about $11,569,000. Finally, Odyssean LLC bought a new stake in Lemonade in the second quarter worth about $1,358,000. 80.30% of the stock is currently owned by institutional investors.
Lemonade Company Profile
Lemonade, Inc (NYSE: LMND) is a New York–based technology-driven insurance carrier that leverages artificial intelligence and behavioral economics to streamline the purchase and management of policies. Founded in 2015, the company offers renters, homeowners, pet, term life and car insurance products tailored for digitally savvy consumers. By automating underwriting and claims processing through chatbots and machine learning, Lemonade aims to deliver a more transparent and user-friendly experience than traditional insurers.
The company’s product suite includes standalone policies for renters and homeowners, customizable pet insurance plans, and term life coverage with simple online applications.
Featured Articles
- Five stocks we like better than Lemonade
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.
